1. Interaction of chiral MS-245 analogs at h5-HT6 receptors;Abate;Bio. Med. Chem. Lett.,2005
2. Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists;Ahmed;Bioorg. Med. Chem. Lett.,2005
3. Ahmed, M., Giblin, G. M. P., Johnson, C. N., Livermore, D. G. H., Miller, N. D., Moss, S. F., and Witty, D.R. (2007). Quinoline compounds capable of binding the CB2 and/or the 5-HT6 receptor, processes for preparing them, and pharmaceutical compositions containing them (65 pp.). WO Patent 2007039219.
4. Ahmed, M., Johnson, C. N., Jones, M. C., MacDonald, G. J., Moss, S. F., Thompson, M., Wade, C. E., and Witty, D. (2003). Preparation of arylsulfonyl(diazacycloalkyl)quinolines for treatment of CNS disorders (48 pp.). WO Patent 2003080580.
5. Ahmed, M., Johnson, C. N., Miller, N. D., Trani, G., and Witty, D. R. (2005b). Preparation of 3-[(hetero)arylsulfonyl]-8-[(aminoalkyl)oxy]quinolines as 5-HT6 receptor antagonists for the treatment of CNS disorders (34 pp.). WO Patent 2005095346.